Pierre Broqua

Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures

Pierre Broqua, Joseph G. Wettstein, M.N. Rocher et al. · Behavioural Pharmacology · 1995 · 197 citations

Chronic Inhibition of Circulating Dipeptidyl Peptidase IV by FE 999011 Delays the Occurrence of Diabetes in Male Zucker Diabetic Fatty Rats

Béatrice Sudre, Pierre Broqua, Richard White et al. · Diabetes · 2002 · 167 citations · Full text

Glucose Tolerance, Insulin Signaling, Gastrointestinal Peptide Hormone +17

Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix

Pierre Broqua, Pierre Rivière, P. Michael Conn et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 150 citations

Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism

Paula Raposinho, D. D. Pierroz, Pierre Broqua et al. · Molecular and Cellular Endocrinology · 2001 · 143 citations

Obesity Syndrome, Chronic Administration, Gastrointestinal Peptide Hormone +17

GnRH Antagonists:  A New Generation of Long Acting Analogues Incorporating<i>p</i>-Ureido-phenylalanines at Positions 5 and 6

Guangcheng Jiang, Jacek Stalewski, Robert Galyean et al. · Journal of Medicinal Chemistry · 2000 · 110 citations · Full text

Pharmaceutical Science, Reporter Gene, New Generation +16